Relaxo Footwears Q3 FY26 results: PAT falls to Rs 26.5 Cr, 9M revenue down 7% YoY

Revenue DeclineEbitda Margin CompressionResults View source PDF Explain this filing

RELAXO · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-3.3%Reaction day

₹395.00

prior close

₹377.60

announcement price

After-mkt

timing

Nifty Microcap 250market · index membership as recorded later (tracked since Jun 2026)-1.3%-2.0% vs market

Footwear peers, median of 10sector-2.0%-1.3% vs sector

On the reaction day the stock moved 2.0 pts less than Nifty Microcap 250 and 1.3 pts less than its Footwear peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.1

10m

+0.3

15m

+0.6

30m

+1.3

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-3.3-1.3-2.0-2.0-1.3

Next day

-3.4+2.4-5.8+0.3-3.7

-4.6+3.8-8.3+1.7-6.2

-5.8+2.7-8.6-0.3-5.6

-6.3+1.9-8.2-1.1-5.3

-6.3+4.6-10.9+1.1-7.4

-5.7+5.1-10.7+1.6-7.3

15d

-10.1+2.1-12.2-0.9-9.2

-15.4-2.1-13.4-6.3-9.1

-32.9-6.4-26.5-13.7-19.2

-24.1+9.5-33.6-5.8-18.3

UpDownMarket · Nifty Microcap 250Sector · Footwear peers, median of 10Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Relaxo Footwears Q3 FY26 (quarter ended Dec 31, 2025): revenue Rs 668 Cr, nearly flat YoY. PAT dropped to Rs 26.54 Cr from Rs 33.01 Cr, a fall of about 20%. Nine-month FY26 revenue Rs 1,951 Cr, down about 7% YoY; 9M PAT Rs 111.6 Cr vs Rs 114.1 Cr. ICRA reaffirmed long term AA with stable outlook and short term A1+ rating. New Labour Codes added Rs 5.72 Cr to employee costs. Statutory auditor issued an unmodified limited review report.

Likely market impact

Weaker profits and a 7% YoY revenue decline over nine months may weigh on the stock, though the stable AA rating offers some comfort.